
US-based Paragon Genomics, founded in 2016, provides diverse business services.
Paragon Genomics, founded in 2016 and based in Hayward, United States, focuses on providing advanced genomic solutions. The company's core mission is to enhance genomic research and diagnostics through their innovative CleanPlex® technology, which offers amplicon-based NGS panels for sequencing. Their products cater to various application markets, including infectious disease, precision oncology, inherited disease, and molecular breeding. Paragon Genomics aims to deliver high-quality, rapid, and customizable NGS target enrichment solutions.
Notable affiliated individuals include Professor Edwin Oh from the University of Nevada, who has utilized Paragon's technology for single viral copy detection in wastewater samples. The company has achieved significant milestones in genomic testing and research, particularly in the areas of infectious disease and precision oncology. Paragon Genomics' impact is evident in its contribution to advancing genomic research methodologies and improving diagnostic accuracy across multiple fields.

Pleno
plenoinc.com

Eureka Genomics
eurekagenomics.com

Paradise Genomics

Clear Labs
clearlabs.com

Pacgenomics
pacgenomics.com
Navipoint Genomics

ClearNote Health

Intact Genomics
intactgenomics.com

Jumpcode Genomics

Singular Genomics

Sequegenics
sequegenics.com

Phase Genomics
phasegenomics.com

Helix
helix.com

Arima Genomics
arimagenomics.com

MicroPure Genomics

Base5 Genomics
b5genomics.com

Cornerstone Genomics
HBM Genomics

Genome Insight
Berry Genomics
berrygenomics.com
Companies similar to Paragon Genomics include Pleno, Eureka Genomics, Paradise Genomics and Clear Labs.
Paragon Genomics was founded in 2015.
Paragon Genomics' headquarters is located in Hayward, CA, US.
Paragon Genomics' most recent funding round was for $8M (USD) in September 2017.
As of Sep 12, 2017, Paragon Genomics has disclosed funding of $8M (USD).
Paragon Genomics has 22 employees as of Feb 4, 2024.